Glibenclamide Therapy in Diabetes MellitusBr Med J 1970; 2 doi: https://doi.org/10.1136/bmj.2.5709.570 (Published 06 June 1970) Cite this as: Br Med J 1970;2:570
- S. K. Bhatia,
- D. R. Hadden,
- D. A. D. Montgomery,
- J. A. Weaver
In an initial trial of glibenclamide in the treatment of maturity onset diabetes mellitus 28 patients were treated for up to one year and no toxic effects or side-effects were encountered. The hypoglycaemic potency of this drug is such that 5 mg. of glibenclamide corresponds to about 1,500 mg. of tolbutamide and 375 mg. of chlorpropamide.